x

Coronavirus

GSK, Sanofi Say COVID-19 Shot Won’t Be Ready Until Late 2021

December 11, 2020

LONDON — Drugmakers GlaxoSmithKline and Sanofi say their potential COVID-19 vaccine won’t be ready until late next year as they seek to improve the shot’s effectiveness in older people.

The companies say early-stage trials showed the vaccine produced an “insufficient” immune response in older adults, demonstrating the need to refine the product so it protects people of all ages.

GSK and Sanofi, based in London and Paris, respectively, say they were confident of the vaccine’s ultimate success due to positive results from other tests.

In adults 18 to 49, the vaccine produced an immune response comparable to patients who had recovered from COVID-19, the companies say.

RELATED

ATHENS – While the New Democracy government is easing health restrictions for rabid anti-vaxxers, those fully vaccinated against COVID-19 may need a fourth shot in the autumn.

Top Stories

General News

FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.

General News

NEW YORK – Meropi Kyriacou, the new Principal of The Cathedral School in Manhattan, was honored as The National Herald’s Educator of the Year.

General News

PHILADELPHIA – The Federation of Hellenic Societies of Philadelphia and Greater Delaware Valley announced that the Evzones, the Presidential Guard of Greece will be participating in the Philadelphia Greek Independence Day Parade on March 20.

Video

Mitsotakis Addresses Boston College Graduation Ceremony

BOSTON - Greek Prime Minister Kyriakos Mitsotakis spoke at the 146th graduation ceremony of Boston College, held on Monday.

Enter your email address to subscribe

Provide your email address to subscribe. For e.g. abc@xyz.com

You may unsubscribe at any time using the link in our newsletter.